Stevanato Group posts 8% Q3 revenue growth but warns of slower 2027 growth, shares tumble
Stevanato Group reported third‑quarter 2026 revenue of €326.1 million, up 8% year‑over‑year, and adjusted earnings per share of €0.16. Management reaffirmed full‑year 2026 guidance but said 2027 revenue growth will moderate to low‑single‑digit because of lower GLP‑1 volumes from a key customer. The outlook triggered a sharp sell‑off, with the stock falling about 26% on the day.
Why it matters
The share price drop to roughly $14.5 reflects investor concern over near‑term growth, potentially increasing short‑term volatility. The unchanged 2026 guidance means the company’s longer‑term targets remain intact, but investors must weigh the temporary slowdown against the firm’s strong Q3 performance.
Key facts
- 1Q3 2026 revenue was €326.1 million, an 8% increase year‑over‑year. stocktitan.net
- 2Adjusted diluted EPS for the quarter was €0.16. stocktitan.net
- 3Adjusted EBITDA rose 14% to €88.8 million, with the margin expanding 150 basis points to 27.2%. investing.com
- 4GLP‑1‑related revenue represented 17‑18% of total quarterly revenue. investing.com
- 5Revenue from non‑GLP biologics grew over 30% in the quarter, offsetting the GLP‑1 decline. finance.yahoo.com
- 6Engineering segment revenue fell 12% to €32.0 million. investing.com
Summary written by AlphAI AI Desk from 11 of 11 sources. Not investment advice. Figures are as stated by the linked sources.